UNSPSC 85543239: Supplement left internal mammary lymphatic with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left internal mammary lymphatic with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07U947Z

UNSPSC 85543239 Supplement left internal mammary lymphatic with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows no relevant recent activity aligned with its clinical procedural scope. The code nominally describes a surgical lymphatic reconstruction technique, but the recent state and local contract opportunities posted under this code are unrelated to that clinical specification—they cover occupational medical surveillance, independent disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical center-of-excellence networks, and emergency medical services for detained youth. State and local governments do not appear to be procuring the specified lymphatic surgical procedure itself under this code; the mismatch between code name and actual procurement suggests either erroneous code assignment in source records or administrative overlap in taxonomy application.

Because the recent opportunities do not reflect purchases aligned with the code's nominal scope, this code presents little actionable market signal for vendors offering services or products related to lymphatic reconstruction. Business development professionals should verify code assignment with individual issuing bodies before investing pursuit effort or should consider whether their capability maps to one of the health administration and staffing services that the recent records actually show—a distinct question from the code's stated clinical scope.